A simple parallel analytical method of prenatal screening.

Gynecol Obstet Invest

Institute of Genetic Diagnosis, School of Pharmacy, State Key Laboratory of Cancer Biology, Fourth Military Medical University, Xi'an, China.

Published: February 2007

Protein microarray has progressed rapidly in the past few years, but it is still hard to popularize it in many developing countries or small hospitals owing to the technical expertise required in practice. We developed a cheap and easy-to-use protein microarray based on dot immunogold filtration assay for parallel analysis of ToRCH-related antibodies including Toxoplasma gondii, rubella virus, cytomegalovirus and herpes simplex virus type 1 and 2 in sera of pregnant women. It does not require any expensive instruments and the assay results can be clearly recognized by the naked eye. We analyzed 186 random sera of outpatients at the gynecological department with our microarray and commercial ELISA kit, and the results showed there was no significant difference between the two detection methods. Validated by clinical application, the microarray is easy to use and has a unique advantage in cost and time. It is more suitable for mass prenatal screening or epidemiological screening than the ELISA format.

Download full-text PDF

Source
http://dx.doi.org/10.1159/000094092DOI Listing

Publication Analysis

Top Keywords

prenatal screening
8
protein microarray
8
simple parallel
4
parallel analytical
4
analytical method
4
method prenatal
4
screening protein
4
microarray
4
microarray progressed
4
progressed rapidly
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!